C&R Research will deploy Taimei Technology’s digital platforms and AI agents across several clinical trial projects.

Momentum in biotech IPOs continued this week as four more companies made their stock market debuts. IPO activity is higher this year by several measures, according to IPO research firm Renaissance ...

Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...

Reimagining clinical trial engagement through community partnership, pragmatic design, and artificial intelligence–enabled ...

As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...

Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

Orientation to Clinical Translational Research (OCTR): Topics covered include T1-T4 translational research, study design for randomized clinical trials and retrospective studies, Good Manufacturing ...

An Investigational Device Exemption (IDE) allows an investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval ...

There is a wealth of data, reviews, articles, and regulatory guidance on how to conduct clinical trials to take a biosimilar from conception to market. However, there is minimal literature describing ...